http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
-
NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
-
NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
-
NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
-
NovaBay Pharma (NBY) Announces Commercial Launch of Avenova Allograft
-
NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
-
NovaBay Pharma (NBY) Enters Agreement with BioStem Technologies (BSEM) to Commercialize Amniotic Tissue Allograft as Avenova Allograft
-
NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft
-
NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results
-
NovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023
-
NovaBay Pharma (NBY) Reports Record Avenova Sales Day
-
NovaBay Pharmaceuticals Reports Record Avenova Sales Day
-
NovaBay Pharma (NBY) Announces Exclusive Amazon Prime Day 2023 Promotions on All Avenova-Branded Products
-
NovaBay Pharmaceuticals Announces Exclusive Amazon Prime Day 2023 Promotions on All Avenova-Branded Products
-
NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Educational Programs and Avenova Product Promotions
-
NovaBay Pharmaceuticals to Showcase its Full Line of Avenova Eyecare Products at the 126th Annual American Optometric Association Congress
-
NovaBay Pharma (NBY) Announces DERMAdoctor’s KP Duty Lotion and Scrub Ultra Duo Set for Dry, Rough, Bumpy Skin to be Featured on QVC
-
NovaBay Pharmaceuticals Announces DERMAdoctor’s KP Duty Lotion and Scrub Ultra Duo Set for Dry, Rough, Bumpy Skin to be Featured on QVC at a Special Price
-
Presenting on the Emerging Growth Conference on May 31 Register Now
-
NovaBay Pharmaceuticals to Present at the Emerging Growth Virtual Conference on May 31, 2023
-
NovaBay Pharmaceuticals Reports First Quarter 2023 Financial Results
-
NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023
-
NovaBay Pharma (NBY) Fulfills $1M Order for NeutroPhase Skin and Wound Cleanser for China Pioneer Pharma Holdings
-
NovaBay Pharmaceuticals Fulfills $1 Million Order for NeutroPhase® Skin and Wound Cleanser for China Pioneer Pharma Holdings
-
NovaBay Pharma (NBY) Announces $3M Convertible Note Financing
-
NovaBay Pharmaceuticals Announces $3.0 Million Convertible Note Financing
-
NovaBay Pharma (NBY) Launches DERMAdoctor’s New Comfort + Joy Psoriasis Therapeutic Moisturizing Cream on the QVC Network
-
NovaBay Pharmaceuticals Launches DERMAdoctor’s New Comfort + Joy Psoriasis Therapeutic Moisturizing Cream on the QVC® Network
-
NovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full Year Financial Results
-
NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023
-
Eyeganics Organic Tears, the Only USDA-Certified Organic Lubricant Eye Drop, Now Available through NovaBay Pharmaceuticals’ Avenova.com and Physician-Dispensed Channel
-
NovaBay Pharma (NBY) launches OTC Avenova Eye Health Support
-
NovaBay Pharmaceuticals Launches Avenova® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health
-
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor’s Eczema Treatment on Two QVC® Shows on February 7
-
NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023
-
NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and China
-
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor’s Eczema Balm
-
NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results
-
NovaBay Pharma (NBY) Announces 1:35 Reverse Stock Split
-
NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split
-
NovaBay Pharmaceuticals to Hold Third Quarter 2022 Conference Call on November 14
-
NovaBay Pharma (NBY) Launches 15% Niacinamide Pore Minimizing Serum
-
NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum
-
NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV
-
NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctor’s Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season
-
NovaBay's (NBY) Avenova and DERMAdoctor to be Featured During the October 11-12 Amazon Prime Early Access Sale
-
NovaBay Pharmaceuticals’ Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale
-
NovaBay Pharma (NBY) Receives NYSE American Notice Regarding Low Share Price
-
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Low Share Price
-
NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference

